Patient-reported Outcomes (PRO) in Patients (pts) with BRCA1/2-altered Metastatic Castration-Resistant Prostate Cancer (mcrpc) Receiving Niraparib (NIRA) with Abiraterone Acetate and Prednisone (AAP): Results from MAGNITUDE Study.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要